María Luisa Aznar - Concepedia

Author

María Luisa Aznar

Also Known As

M. L. Aznar, M.L. Aznar, Maria Aznar, Maria L Aznar, Maria Luisa Aznar, Maria Luísa Aznar, María Aznar, María L Aznar, María L. Aznar, María L. Aznar-Ruiz-de-Alegría

Publications

598

Citations

H-Index

Concepts

All Affiliations

Universitat Autònoma de Barcelona Vall d'Hebron Hospital Universitari Generalitat de Catalunya Instituto de Salud Carlos III Hebron University

About

María Luisa Aznar is an author at Universitat Autònoma de Barcelona specializing in medicine, infection control, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	165
2	Public Health	1	1	76
3	Emergency Medicine	1	1	37
4	Epidemiology	1	1	76
5	Pharmacology	1	1	38

María Luisa Aznar

Publications

381

Citations

H-Index

Page 1

	Year	Citations
Impact of the COVID-19 pandemic on tuberculosis management in Spain María Luisa Aznar, Juan Espinosa‐Pereiro, Núria Saborit, International Journal of Infectious Diseases MedicineTuberculosis PreventionCovid-19 PandemicTuberculosisDisease Outbreak	2021	76
Role of Postoperative Antimicrobials in Cleft Palate Surgery María Luisa Aznar, Björn Schönmeyr, Gastón Echániz, Plastic & Reconstructive Surgery	2015	50
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro, The Lancet Infectious Diseases Chronic Chagas DiseaseClinical TherapeuticMedicineClinical TrialsPharmacotherapy	2024	38
A pragmatic approach for mortality prediction after surgery in infective endocarditis: optimizing and refining EuroSCORE Núria Fernández-Hidalgo, I. Ferreria-González, Josep Ramón Marsal, Clinical Microbiology and Infection Prognostic EvaluationHeart FailureMortality PredictionPrognosisPatient Safety	2018	37
Field and laboratory comparative evaluation of a LAMP assay for the diagnosis of urogenital schistosomiasis in Cubal, Central Angola Javier Gandasegui, Pedro Fernández‐Soto, Elena Dacal, Tropical Medicine & International Health	2018	29
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada María Luisa Aznar, Theodore K. Marras, Ahmed Said Elshal, BMC Pharmacology and Toxicology	2019	28
Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola María Luisa Aznar, Ariadna Rando‐Segura, María Milagros Moreno, American Journal of Tropical Medicine and Hygiene	2019	26
Beta-Hemolytic Streptococcal Infective Endocarditis: Characteristics and Outcomes From a Large, Multinational Cohort Núria Fernández-Hidalgo, Amal Gharamti, María Luisa Aznar, Open Forum Infectious Diseases	2020	21
Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study María Luisa Aznar, Ariadna Rando‐Segura, M Moreno, The International Journal of Tuberculosis and Lung Disease	2019	15
Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola Ariadna Rando‐Segura, María Luisa Aznar, María Milagros Moreno, BMC Infectious Diseases	2021	15

Page 1